Loading...
EBR Systems, Inc.
EBR.AX•ASX
HealthcareMedical - Devices
$1.06
$-0.07(-6.17%)
EBR Systems, Inc. (EBR.AX) Stock Overview
Explore EBR Systems, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Stats data is not available for EBR.AXStats details for EBR.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for EBR.AXAnalyst Recommendations details for EBR.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. The company offers WiSE cardiac resynchronization therapy system that uses a proprietary wireless technology to deliver pacing stimulation directly to the inside of the left ventricle of the heart. Its products are used to eliminate lead complications, such as placement difficulty, unintended nerve stimulation, dislodgement, extraction, and repositioning. The company was incorporated in 2003 and is based in Sunnyvale, California.
CEO
Mr. John Graham McCutcheon B.A., M.B.A.
Employees
89
Headquarters
480 Oakmead Parkway, Sunnyvale, CA
Founded
2021